This document has been prepared by the Department of Health to assist prescribers who have not undertaken the Medication Assisted Treatment of Opioid Dependence (MATOD) prescriber training, with general information on the key regulatory and policy requirements associated with the safe, appropriate and lawful prescribing of buprenorphine.
Use this document with:
- Policy for Maintenance Pharmacotherapy for Opioid Dependence (2016)
- Pharmacotherapy policy addendum – Long-acting injectable buprenorphine.
- Policies and guidelines
- Date published
- 15 Apr 2021
- 6 pages
Reviewed 16 April 2021